newsfilter
← Latest News
PR Newswire·

Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement

FORT COLLINS, Colo., Aug. 12, 2021 /PRNewswire/ -- Cytocom, Inc. (NASDAQ:CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced a collaboration agreement to